The North America Blood Component Utilization Market is positioned for steady expansion through 2034, supported by mature blood donation systems, advanced hospital laboratories, established transfusion medicine departments, and widespread patient blood management programs. The region is expected to account for 35–39% of the global market in 2025 and expand at a 3.70–4.20% CAGR...

The US Blood Component Utilization Market represents the dominant national market within North America, estimated to account for 72–76% of the regional market in 2025 and projected to grow at a 3.80–4.20% CAGR through 2034. Growth is supported by the country's extensive network of academic medical centers, trauma systems, cancer centers, blood services, and specialized transfusion...